[Balloon pulmonary valvuloplasty, 15-year experience at the Siglo XXI IMSS National Medical Center].

Autor:	Juárez Rodríguez M; Hospital de Cardiología CMN Siglo XXI, IMSS, México DF Av. Cuauhtémoc 330 Col Doctores C.P. 06720 Deleg, Cuauhtémoc., Alva Espinosa C, Ledesma Velasco M, Lázala Rodríguez G, Jiménez Arteaga S, Sánchez Soberanes A, Ortegón Cardeña J, David Gómez F, Hernández González M, Magaña Serrano J
Jazyk:	Spanish; Castilian
Zdroj:	Archivos de cardiologia de Mexico [Arch Cardiol Mex] 2003 Jul-Sep; Vol. 73 (3), pp. 190-6.
Abstrakt:	Objective: To evaluate 15 years of experience with balloon pulmonary valvuloplasty in a single third level health care center. Material and Methods: Hundred-fifty patients underwent the procedure, 73 (48%) men and 77 (52%) women, mean age 10.5 +/- 11.3 years. Results: The initial systolic gradient decreased from 86 +/- 35 to 21.67 +/- 12.20 mm Hg, p < 0.001, whereas the initial right ventricular systolic pressure decreased from 106 +/- 34.8 to 53 +/- 27 mm Hg, p < 0.0001. At the end of the follow-up, 48 +/- 44 months, the systolic gradient was 13.43 +/- 8.73 mm Hg, p < 0.001. Major complications occurred in 9 (6.4%) patients. Immediate technical success was achieved in 111 (74%) patients and failure in 39 (26%). At the end of the follow-up period, successful outcomes were achieved in 104 (89.6%); in contrast, failures were present in 12 (10.4%) patients, p < 0.001. Death occurred in 2 (1.33%) patients. The predictors for failure were age < 1.5 +/- 1-33 years (p < 0.004), dysplastic valve (p < 0.001), high initial systolic gradient (p < 0.002), and high initial systolic right ventricular pressure (p < 0.0001). Conclusion: Balloon pulmonary valvuloplasty is an effective, safe, and first choice treatment for congenital pulmonary valve stenosis.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu